(Q35627613)

9 August 2017

1 reference

title

Pseudomonal infections in patients with COPD: epidemiology and management (English)

1 reference

chronic obstructive pulmonary disease

9 August 2017

1 reference

David Lieberman

1

1 reference

PubMed ID

14719985

9 August 2017

Devora Lieberman

series ordinal

2

1 reference

9 August 2017

1 January 2003

1 reference

Treatments in Respiratory Medicine

9 August 2017

1 reference

9 August 2017

2

1 reference

9 August 2017

6

1 reference

9 August 2017

459-468

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03256673

9 August 2017

0 references

cites work

Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

The chronic obstructive pulmonary disease exacerbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

Microbiology of airway disease in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

Isolation of mucoid strains of Pseudomonas aeruginosa from non-cystic-fibrosis patients and characterisation of the structure of their secreted alginate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

Aluminium potroom asthma: the Norwegian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

Efficacy and tolerability of twice-daily ciprofloxacin 750 mg in the treatment of patients with acute exacerbations of chronic bronchitis and pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

Clinical effectiveness of levofloxacin in patients with acute purulent exacerbations of chronic bronchitis: the relationship with in-vitro activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

Comparative in-vitro activity of levofloxacin against isolates of bacteria from adult patients with community-acquired lower respiratory tract infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

Randomized, double-blind study of prulifloxacin versus ciprofloxacin in patients with acute exacerbations of chronic bronchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

Infectious etiologies in acute exacerbation of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

A critical review of the fluoroquinolones: focus on respiratory infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

Antimicrobial activity evaluations of gatifloxacin, a new fluoroquinolone: contemporary pathogen results from a global antimicrobial resistance surveillance program (SENTRY, 1997).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

Acute exacerbations of chronic bronchitis: what role for the new fluoroquinolones?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

Cost-effective therapy for acute exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

Relationship Between Bacterial Flora in Sputum and Functional Impairment in Patients With Acute Exacerbations of COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256673

21 January 2018

Identifiers

DOI

10.1007/BF03256673

1 reference

9 August 2017

1 reference

PubMed ID

14719985